Heart Disease Clinical Trials in Ohio

Showing 241-260 of 458 trials

Rheos System for the Treatment of HFpEF Heart Failure

NCT00957073

The purpose of this clinical investigation (NCT00957073) is to continue long-term follow-up of device arm subjects enrolled in the HOPE4HF Trial, utilizing the BAROSTIM NEO™ LEGACY device for Implantable Pulse Generator (IPG) replacements.

Heart Failure

CVRx, Inc.19 participantsStarted Aug 2009

Mobile, Alabama, United States • Inglewood, California, United States • Los Angeles, California, United States +19 more locations

COMPLETEDPhase 232 miles

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

NCT01951625

Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to standard therapy for heart failure with reduced ejection fraction (HFrEF).

Heart Failure

Bayer456 participantsStarted Nov 2013

Fountain Valley, California, United States • Wilmington, Delaware, United States • Fort Lauderdale, Florida, United States +154 more locations

Rheos System for the Treatment of HFpEF Heart Failure

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

Heart Disease Trials in Other Cities

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Early Elimination of Premature Ventricular Contractions in Heart Failure

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study

EVOLVE Short DAPT Study

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure

Personalized CRT - MPP Post Approval Study

Model 4396 Left Ventricular (LV) Lead Chronic Performance Study

A Study of CLR325 in Chronic Stable Heart Failure Patients.

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines

Heart Sounds Registry

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

SynCardia 70cc TAH-t for Destination Therapy (DT)

HBP Device EGM Data Collection

Self-Management App for Patients With Left-Ventricular Assist Devices

A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

Other Conditions in Ohio